1. OC-0503: Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial. (April 2018) Authors: Zilli, T.; Jorcano, S.; Bral, S.; Rubio, C.; Bruynzeel, A.; Oliveira, A.; Abacioglu, U.; Minn, H.; Symon, Z.; Miralbell, R. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0609 Urethra-sparing SBRT for prostate cancer: quality assurance of a randomized phase II trial. (April 2019) Authors: Jaccard, M.; Zilli, T.; Dubouloz, A.; Tsang, L.; Zvi, S.; Linthout, N.; Bral, S.; Verbakel, W.; Bruynzeel, A.; Björkqvist, M.; Minn, H.; Escude, L.; Jorcano, S.; Lencart, J.; Oliveira, A.; Ozen, Z.; Abacioglu, U.; Pérez-Moreno, J.M.; Rubio, C.; Rouzaud, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-0061: Does the dose to penile bulb/internal pudendal arteries matter for erectile dysfunction post-SBRT?. (November 2020) Authors: Lamanna, G.; Jorcano, S.; Bral, S.; Rubio, C.; Oliveira, A.; Bottero, M.; Abacioglu, U.; Achard, V.; Minn, H.; Symon, Z.; Zilli, T.; Miralbell, R. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0721: Short vs protracted urethra-sparing prostate SBRT: feasibility and early toxicity from a randomized phase II trial. (April 2015) Authors: Zilli, T.; Bruynzeel, A.; Minn, H.; Sánchez-Saugar, E.; Oliveira, A.; Bral, S.; Jorcano, S.; Abacioglu, U.; Symon, Z.; Miralbell, R. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PV-0552: Urethra-sparing SBRT for prostate cancer: acute toxicity results from a randomized phase II trial. (May 2017) Authors: Zilli, T.; Jorcano, S.; Bral, S.; Rubio, C.; Bruynzeel, A.; Oliveira, A.; Abacioglu, U.; Minn, H.; Symon, Z.; Miralbell, R. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect. (15th February 2016) Authors: Zilli, T.; Symon, Z.; Bral, S.; Bruynzeel, A.; Minn, H.; Jorcano, S.; Oliveira, A.; Abacioglu, U.; Rubio, C.; Miralbell, R. Journal: Radiotherapy and oncology Issue: Volume 118(2016)Supplement 1 Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗